Cynvenio Launches Newest LiquidBiopsy HER2 Expression Test

High sensitivity blood test allows measurement of HER2 over-expression in patients after primary tumor has been removed and tissue biopsy is no longer available - provides novel way to monitor...(PRWeb August 24, 2017)Read the full story at http://www.prweb.com/releases/2017/08/prweb14631277.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
More News: HER2 | Pharmaceuticals